Mark S. Gold, M.D.

Board Member
Dr. Mark Gold

Dr. Mark S. Gold is a teacher of the year, translational researcher, author, mentor, and inventor best known for his work on the brain systems underlying the effects of opioid drugs, methamphetamine,  cocaine, tobacco, and food. Gold was a Professor, Eminent Scholar, Distinguished Professor, Distinguished Alumni Professor, Chairman, Emeritus Eminent Scholar during his 25 years at the University of Florida College of Medicine. He is an author and inventor who has published over 1,000 peer-reviewed scientific articles, 20 textbooks, popular-general audience books, and physician practice guidelines. His first academic appointment was at Yale University School of Medicine in 1978, where he also trained. Gold and his Yale colleagues helped develop the neuroanatomy of opioid addiction and withdrawal. Gold was co-inventor of the use of clonidine in opiate withdrawal, and with Kleber reported on the anti-withdrawal efficacy of Lofexidine in 1980. Gold developed the dopamine hypothesis for cocaine addiction and anhedonia in 1984 and 1985, which has informed most theory and research on drug dependence since. He has worked closely for a decade from animal to man in a comprehensive methamphetamine research program with Jean Lud Cadet, MD. Gold has worked closely with major academic institutions, including Yale, Mayo Clinic, U.F., Tulane, Georgia, and Brandeis, to develop addiction research and training programs. He has mentored medical students, graduate students, fellows, and researchers at these institutions. He has also pioneered the study of tobacco dependence and second-hand tobacco smoke and opium and marijuana smoke. He has also worked as a prevention team member for the Media Partnership for a Drug-Free America, DARE, DEA Educational Foundation, PRIDE, American Council for Drug Education, CASA, and Addiction Policy Forum. Gold is currently Professor (Adjunct) at Washington University in St. Louis, where he is a teacher, mentor, and co-investigator on several funded grants, including projects on naloxone and novel treatments for opioid use disorders with a team of inventors at Washington University in St Louis.

Gold has received awards from many State and National awards for research and service over his long career. He has been awarded major national awards for his neuroscience research including the annual Foundations Fund Prize (APA) for research in Psychiatry, NAATP Annual Nelson J Bradley Award, DEA 30 Years of Service (2014), the American Foundation for Addiction Research’s Lifetime Achievement Award (2014), the McGovern Award for Lifetime Achievement (ASAM-ABAM 2015) for contributions to the understanding and treatment of addiction, Addiction Policy Forum’s Pillar of Excellence Award (2019) and the Chairman of (2006) Psychiatry Chair Summit Annual Award (2020). He was awarded Distinguished Alumni Awards at Yale University, U.F., and Washington University. He was elected to the Wall of Fame at the U.F. College of Medicine, where the White Coat Ceremony is named after him.